Investors Asset Management of Georgia Inc. GA ADV trimmed its stake in Equifax Inc. (NYSE:EFX - Free Report) by 10.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 88,498 shares of the credit services provider's stock after selling 10,200 shares during the quarter. Equifax makes up 12.3% of Investors Asset Management of Georgia Inc. GA ADV's holdings, making the stock its biggest position. Investors Asset Management of Georgia Inc. GA ADV owned approximately 0.07% of Equifax worth $26,006,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Capital International Investors grew its stake in shares of Equifax by 2.5% during the 1st quarter. Capital International Investors now owns 14,045,398 shares of the credit services provider's stock worth $3,757,425,000 after acquiring an additional 342,170 shares during the period. Vanguard Group Inc. boosted its position in Equifax by 1.0% during the first quarter. Vanguard Group Inc. now owns 14,033,448 shares of the credit services provider's stock worth $3,754,228,000 after purchasing an additional 137,961 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Equifax by 4.9% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,276,798 shares of the credit services provider's stock worth $1,036,952,000 after purchasing an additional 200,665 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Equifax by 2.4% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,044,561 shares of the credit services provider's stock valued at $738,184,000 after purchasing an additional 70,091 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its stake in shares of Equifax by 72.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,514,093 shares of the credit services provider's stock valued at $405,051,000 after buying an additional 633,887 shares in the last quarter. 96.20% of the stock is owned by institutional investors.
Equifax Price Performance
Shares of Equifax stock traded down $0.63 during trading on Friday, hitting $264.39. 844,150 shares of the stock traded hands, compared to its average volume of 852,421. The stock has a market cap of $32.77 billion, a price-to-earnings ratio of 58.75, a PEG ratio of 2.54 and a beta of 1.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.96. Equifax Inc. has a 52 week low of $170.62 and a 52 week high of $309.63. The firm's fifty day moving average is $289.99 and its 200-day moving average is $264.12.
Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 16th. The credit services provider reported $1.85 EPS for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. The business had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. Equifax had a net margin of 10.07% and a return on equity of 18.56%. The business's quarterly revenue was up 9.3% on a year-over-year basis. During the same period last year, the business earned $1.76 earnings per share. Research analysts expect that Equifax Inc. will post 7.29 EPS for the current fiscal year.
Equifax Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Tuesday, September 3rd were paid a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 0.59%. The ex-dividend date was Tuesday, September 3rd. Equifax's dividend payout ratio is presently 34.67%.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on EFX shares. Morgan Stanley lifted their price objective on shares of Equifax from $250.00 to $271.00 and gave the company an "equal weight" rating in a research note on Thursday, September 12th. Needham & Company LLC reiterated a "buy" rating and set a $350.00 price objective on shares of Equifax in a research note on Monday, October 28th. Robert W. Baird lifted their target price on Equifax from $290.00 to $333.00 and gave the company an "outperform" rating in a report on Friday, October 18th. JPMorgan Chase & Co. upped their price target on Equifax from $300.00 to $304.00 and gave the company an "overweight" rating in a research report on Friday, October 18th. Finally, Wells Fargo & Company restated a "buy" rating on shares of Equifax in a research report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $310.47.
Check Out Our Latest Stock Report on EFX
Insider Buying and Selling at Equifax
In other news, CEO Mark W. Begor sold 58,304 shares of Equifax stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $270.49, for a total value of $15,770,648.96. Following the transaction, the chief executive officer now owns 109,183 shares in the company, valued at approximately $29,532,909.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Mark W. Begor sold 58,304 shares of the firm's stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $270.49, for a total value of $15,770,648.96. Following the transaction, the chief executive officer now owns 109,183 shares in the company, valued at approximately $29,532,909.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Carla Chaney sold 3,000 shares of the company's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $281.85, for a total transaction of $845,550.00. Following the sale, the executive vice president now owns 10,875 shares of the company's stock, valued at $3,065,118.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 62,304 shares of company stock worth $16,889,119 over the last three months. Company insiders own 1.57% of the company's stock.
Equifax Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report